Does OCRELIZUMAB Cause Hypertonic bladder? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Hypertonic bladder have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.1% of all adverse event reports for OCRELIZUMAB.
45
Reports of Hypertonic bladder with OCRELIZUMAB
0.1%
of all OCRELIZUMAB reports
0
Deaths
16
Hospitalizations
How Dangerous Is Hypertonic bladder From OCRELIZUMAB?
Of the 45 reports, 16 (35.6%) required hospitalization.
Is Hypertonic bladder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Hypertonic bladder?
GABAPENTIN (114)
INTERFERON BETA-1A (114)
DIMETHYL (111)
TAMSULOSIN (103)
BACLOFEN (99)
RABEPRAZOLE (91)
AMLODIPINE (90)
LORAZEPAM (90)
ROSUVASTATIN (89)
DOXEPIN (85)
Which OCRELIZUMAB Alternatives Have Lower Hypertonic bladder Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE